BACKGROUND: Gut hormones and their receptors are considered important in the control of feeding behavior. The gut hormone peptide-YY (PYY) has anorexic effects via the inhibitory neuropeptide Y2 receptor (Y2R) highly expressed in orexigenic NPY/AGRP neurons within the arcuate nucleus, a major integrator of appetite control in the hypothalamus. DESIGN: Genetic case-control association study of single nucleotide polymorphisms (SNPs) in Y2R and PYY. SUBJECTS: Swedish Caucasians comprising 148 lean, 129 overweight/obese and 226 morbidly obese men. MEASUREMENTS: Genotypes of the common, silent and conserved SNP Y2R 585T>C and the common SNP PYY Arg72Thr, as well as various obesity-related clinical parameters. RESULTS: Obese men had a lower allele and homozygosity frequency of the common allele 585T>C:T which was particularly evident comparing morbidly obese with lean men (P = 0.002), and analyzing dependence between continuous body mass index (BMI) and genotype (P = 0.002). In agreement, systolic blood pressure tended to be lower in those homozygous for allele T, which was not explained by the BMI - genotype dependence. We found no association to obesity for the PYY Arg72Thr polymorphism, which is located nearby the essential carboxy terminal. CONCLUSION: A common and conserved variant of the PYY and NPY receptor Y2R is less prevalent among obese compared to among lean Swedish men. This suggests that the common Y2R variant is protective against obesity. Our findings further implicate Y2R in food intake regulation.
BACKGROUND: Gut hormones and their receptors are considered important in the control of feeding behavior. The gut hormone peptide-YY (PYY) has anorexic effects via the inhibitory neuropeptide Y2 receptor (Y2R) highly expressed in orexigenic NPY/AGRP neurons within the arcuate nucleus, a major integrator of appetite control in the hypothalamus. DESIGN: Genetic case-control association study of single nucleotide polymorphisms (SNPs) in Y2R and PYY. SUBJECTS: Swedish Caucasians comprising 148 lean, 129 overweight/obese and 226 morbidly obesemen. MEASUREMENTS: Genotypes of the common, silent and conserved SNP Y2R 585T>C and the common SNP PYY Arg72Thr, as well as various obesity-related clinical parameters. RESULTS:Obesemen had a lower allele and homozygosity frequency of the common allele 585T>C:T which was particularly evident comparing morbidly obese with lean men (P = 0.002), and analyzing dependence between continuous body mass index (BMI) and genotype (P = 0.002). In agreement, systolic blood pressure tended to be lower in those homozygous for allele T, which was not explained by the BMI - genotype dependence. We found no association to obesity for the PYY Arg72Thr polymorphism, which is located nearby the essential carboxy terminal. CONCLUSION: A common and conserved variant of the PYY and NPY receptor Y2R is less prevalent among obese compared to among lean Swedish men. This suggests that the common Y2R variant is protective against obesity. Our findings further implicate Y2R in food intake regulation.
Authors: Yechiel Friedlander; Guo Li; Myriam Fornage; O Dale Williams; Cora E Lewis; Pamela Schreiner; Mark J Pletcher; Daniel Enquobahrie; Michelle Williams; David S Siscovick Journal: Ann Hum Genet Date: 2010-07-14 Impact factor: 1.670
Authors: Steven C Hunt; Sandra J Hasstedt; Yuanpei Xin; Brian K Dalley; Brett A Milash; Emanuel Yakobson; Richard E Gress; Lance E Davidson; Ted D Adams Journal: Obesity (Silver Spring) Date: 2011-08-04 Impact factor: 5.002
Authors: S S Torekov; L H Larsen; G Andersen; A Albrechtsen; C Glümer; K Borch-Johnsen; T Jørgensen; T Hansen; O Pedersen Journal: Diabetologia Date: 2006-09-22 Impact factor: 10.122
Authors: Zhiyun Wei; Kuixing Zhang; Gen Wen; Karthika Balasubramanian; Pei-an B Shih; Fangwen Rao; Ryan S Friese; Jose P Miramontes-Gonzalez; Geert W Schmid-Schoenbein; Hyung-Suk Kim; Sushil K Mahata; Daniel T O'Connor Journal: J Hypertens Date: 2013-01 Impact factor: 4.844
Authors: Pei-An Betty Shih; Lei Wang; Stephane Chiron; Gen Wen; Caroline Nievergelt; Manjula Mahata; Srikrishna Khandrika; Fangwen Rao; Maple M Fung; Sushil K Mahata; Bruce A Hamilton; Daniel T O'Connor Journal: J Clin Endocrinol Metab Date: 2009-10-09 Impact factor: 5.958